nav Searchuser
Maxunitech Inc.
Beijing Multigrass Formulation Co., Ltd.

Monsanto Focus on Conventional Breeding in Europeqrcode

Jul. 26, 2013

Favorites Print
Jul. 26, 2013
Monsanto is to invest several hundred million dollars in Europe over a decade to expand their conventional seed production and breeding. By doing so, Monsanto will retain all pending genetically modified (GM) applications except for MON 810.

In a statement, the company said: "Biotech crops are highly successful in the rest of the world. In order to fully support both of these success stories, we will no longer be pursuing approvals for cultivation of new biotech crops in Europe.

"Instead, we will focus on enabling imports of biotech crops into the EU and the growth of our current business there."

Picture 0/1200

More from AgroNews


Annual Review 2019 2019 CRO & CRAO Manual
2019 Market Insight Chinese issue of 2019 Market Insight
2019 India Pesticide Suppliers Guide 2019 Biologicals Special
Subscribe Comment


Subscribe Email: *
Mobile Number:  


Picture 0/1200

Subscribe to daily email alerts of AgroNews.